Nationwide Children's Events & Announcements
Viewing: 1-10 of 972 | All
Jul 14, 2025
New Study Finds Sharp Increase in Nicotine Pouch Ingestions Among Young Children
A new study reveals that ingestions of nicotine pouches by young children have surged in recent years. Researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital and the Central Ohio Poison Center analyzed calls to U.S. poison centers and found an alarming 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023. Nicotine pouches were also more likely to be associated with serious medical outcomes or hospital admissions than other nicotine products like gum/lozenges, e-liquids, powder/granules, and tablets/capsules/caplets.

Jun 18, 2025
Nationwide Children’s Hospital Physician Named Editor-In-Chief of Pediatrics
Alex Kemper, MD, division chief of Primary Care Pediatrics at Nationwide Children’s Hospital, has been named editor-in-chief of Pediatrics, the official journal of the American Academy of Pediatrics (AAP), effective in July.

Jun 09, 2025
Modern Healthcare Names Catherine Krawczeski, MD, to List of “50 Most Influential Clinical Executives”
Catherine Krawczeski, MD, physician-in-chief and chief medical officer at Nationwide Children’s Hospital, has been named to Modern Healthcare’s 2025 list of “50 Most Influential Clinical Executives.”

Jun 02, 2025
Alexander Bishop, DPhil, Named Director of the Center for Childhood Cancer Research at Nationwide Children’s Hospital
Nationwide Children’s Hospital welcomes Alexander Bishop, DPhil, as the director of the Center for Childhood Cancer Research in the Abigail Wexner Research Institute (AWRI), effective June 1, 2025. He will also serve as principal investigator in the center, as well as the Richard J. Solove Endowed Professor and Chair in Cancer Clinical Developmental Therapeutics at The Ohio State University College of Medicine.
May 28, 2025
Nationwide Children’s Hospital Delivers its First Infusion of CASGEVY™ for Patient with Sickle Cell Disease
Nationwide Children’s Hospital delivered its first commercial infusion of CASGEVY™ to 17-year-old Carlos A. from Dayton, Ohio. Today, Carlos is thriving at home, pain-free.

May 19, 2025
Experts Provide Practical Advice for Families Worried About Picky Eaters
Many families with young children experience bouts of picky eating, from toddlers who want to eat only chicken nuggets and mac and cheese, to kids who love sweet fruit but will not touch leafy green vegetables. Getting picky eaters to try new, healthier foods can be a challenge for parents and caregivers to navigate.

May 05, 2025
Maitreya Coffey, MD, Named Chief Quality Officer at Nationwide Children’s Hospital
Nationwide Children’s Hospital has named Maitreya Coffey, MD, as the hospital’s inaugural Chief Quality Officer (CQO), effective May 5. As part of this role, Dr. Coffey will oversee Nationwide Children’s Center for Clinical Excellence.
May 05, 2025
Nationwide Children’s Hospital Hosts Free Summer Events for Families
Children and families are invited to get outdoors and get active this summer with the return of PlayStreets, free community events for children and their families featuring food, entertainment and a place to play.

Apr 28, 2025
Medallion for Scientific Achievement Awarded to Nationwide Children’s Physician
The American Surgical Association has awarded Gail Besner, MD, chief of Pediatric Surgery at Nationwide Children’s Hospital, the Medallion for Scientific Achievement, the highest honor bestowed by the association.
Mar 07, 2025
FDA Grants Nationwide Children’s Hospital Researchers Safe-To-Proceed Authorization on First-In-World CAR-NK Cells Made with CRISPR/AAV
Researchers at Nationwide Children’s Hospital have received safe-to-proceed approval from the Food and Drug Administration (FDA) for Universal-Donor CD38KO CD33CAR-NK cells, to be studied in a forthcoming clinical trial. The Phase 1 trial will study the safety of the novel therapy in patients with advanced, high-risk acute myeloid leukemia (AML).